TP53 and non-small cell lung carcinoma: Moreover, we found that nicotine treatment of NSCLC cells upregulated the levels of VEGF and cell survival via α7nAChR and/or β-Ars, while GABA and/or p53 led to downregulation of VEGF levels [21].